<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Sánchez Fructuoso, A.</author>
      <author>Ruiz, J.C.</author>
      <author>Franco, A.</author>
      <author>Diekmann, F.</author>
      <author>Redondo, D.</author>
      <author>Calviño, J.</author>
      <author>Serra, N.</author>
      <author>Aladrén, M.J.</author>
      <author>Cigarrán, S.</author>
      <author>Manonelles, A.</author>
      <author>Ramos, A.</author>
      <author>Gómez, G.</author>
      <author>González Posada, J.M.</author>
      <author>Andrés, A.</author>
      <author>Beneyto, I.</author>
      <author>Muñiz, A. L.</author>
      <author>Perelló, M.</author>
      <author>Lauzurica, R.</author>
    </authors>
  </contributors>
  <titles>
    <title>Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study</title>
    <secondary-title>Clin. transplant.</secondary-title>
  </titles>
  <doi>10.1111/ctr.13767</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2020</year>
    <pub-dates>
      <date>2020</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>